O Shaughnessy Asset Management LLC increased its position in shares of LifeVantage Corp (NASDAQ:LFVN) by 38.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 46,776 shares of the company’s stock after acquiring an additional 12,954 shares during the quarter. O Shaughnessy Asset Management LLC owned approximately 0.33% of LifeVantage worth $617,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently made changes to their positions in LFVN. Manatuck Hill Partners LLC increased its stake in LifeVantage by 510.2% during the third quarter. Manatuck Hill Partners LLC now owns 454,570 shares of the company’s stock worth $4,996,000 after purchasing an additional 380,070 shares during the period. Renaissance Technologies LLC grew its position in shares of LifeVantage by 36.1% during the third quarter. Renaissance Technologies LLC now owns 1,011,805 shares of the company’s stock worth $11,120,000 after buying an additional 268,354 shares in the last quarter. Acadian Asset Management LLC grew its position in shares of LifeVantage by 190.9% during the third quarter. Acadian Asset Management LLC now owns 291,624 shares of the company’s stock worth $3,204,000 after buying an additional 191,382 shares in the last quarter. BlackRock Inc. grew its position in shares of LifeVantage by 210.9% during the third quarter. BlackRock Inc. now owns 238,160 shares of the company’s stock worth $2,618,000 after buying an additional 161,555 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of LifeVantage by 76.5% during the third quarter. Dimensional Fund Advisors LP now owns 258,262 shares of the company’s stock worth $2,838,000 after buying an additional 111,974 shares in the last quarter. 32.30% of the stock is currently owned by hedge funds and other institutional investors.
Shares of LifeVantage stock traded up $0.04 on Friday, reaching $14.46. 1,256 shares of the company were exchanged, compared to its average volume of 143,102. LifeVantage Corp has a 1-year low of $3.20 and a 1-year high of $17.08. The company has a market cap of $202.49 million, a PE ratio of 28.31 and a beta of 0.76. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.06 and a current ratio of 1.52.
LifeVantage (NASDAQ:LFVN) last announced its quarterly earnings data on Monday, February 4th. The company reported $0.13 EPS for the quarter. The business had revenue of $58.17 million during the quarter. LifeVantage had a return on equity of 35.08% and a net margin of 2.92%. On average, sell-side analysts predict that LifeVantage Corp will post 0.49 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “LifeVantage Corp (LFVN) Shares Bought by O Shaughnessy Asset Management LLC” was first reported by Fairfield Current and is the property of of Fairfield Current. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.fairfieldcurrent.com/news/2019/03/15/o-shaughnessy-asset-management-llc-increases-position-in-lifevantage-corp-lfvn.html.
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.
Read More: Cash Flow Analysis in Stock Selection
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.